866-997-4948(US-Canada Toll Free)

United States Cytomegalovirus Therapeutics Market Report 2017

Published By :

QYResearch

Published Date : Apr 2017

Category :

Pharmaceutical

No. of Pages : 104 Pages

In this report, the United States Cytomegalovirus Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Cytomegalovirus Therapeutics in these regions, from 2012 to 2022 (forecast).

United States Cytomegalovirus Therapeutics market competition by top manufacturers/players, with Cytomegalovirus Therapeutics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
AbbVie
Actavis
Clinigen Group
Merck
Perrigo Company
Roche
Valeant Pharmaceuticals
...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Ganciclovir/Valganciclovir
Foscarnet
Cidofovir
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cytomegalovirus Therapeutics for each application, including
CMV Retinitis
Pneumonia
Gastrointestinal Ulcers
Encephalitis
Mouth Ulcers
Pharyngitis

Table of Contents

United States Cytomegalovirus Therapeutics Market Report 2017
1 Cytomegalovirus Therapeutics Overview
1.1 Product Overview and Scope of Cytomegalovirus Therapeutics
1.2 Classification of Cytomegalovirus Therapeutics by Product Category
1.2.1 United States Cytomegalovirus Therapeutics Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Cytomegalovirus Therapeutics Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Ganciclovir/Valganciclovir
1.2.4 Foscarnet
1.2.5 Cidofovir
1.3 United States Cytomegalovirus Therapeutics Market by Application/End Users
1.3.1 United States Cytomegalovirus Therapeutics Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 CMV Retinitis
1.3.3 Pneumonia
1.3.4 Gastrointestinal Ulcers
1.3.5 Encephalitis
1.3.6 Mouth Ulcers
1.3.7 Pharyngitis
1.4 United States Cytomegalovirus Therapeutics Market by Region
1.4.1 United States Cytomegalovirus Therapeutics Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.3 Southwest Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.5 New England Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.6 The South Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.4.7 The Midwest Cytomegalovirus Therapeutics Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cytomegalovirus Therapeutics (2012-2022)
1.5.1 United States Cytomegalovirus Therapeutics Sales and Growth Rate (2012-2022)
1.5.2 United States Cytomegalovirus Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Cytomegalovirus Therapeutics Market Competition by Players/Suppliers
2.1 United States Cytomegalovirus Therapeutics Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cytomegalovirus Therapeutics Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cytomegalovirus Therapeutics Average Price by Players/Suppliers (2012-2017)
2.4 United States Cytomegalovirus Therapeutics Market Competitive Situation and Trends
2.4.1 United States Cytomegalovirus Therapeutics Market Concentration Rate
2.4.2 United States Cytomegalovirus Therapeutics Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cytomegalovirus Therapeutics Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cytomegalovirus Therapeutics Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Cytomegalovirus Therapeutics Sales and Market Share by Region (2012-2017)
3.2 United States Cytomegalovirus Therapeutics Revenue and Market Share by Region (2012-2017)
3.3 United States Cytomegalovirus Therapeutics Price by Region (2012-2017)

4 United States Cytomegalovirus Therapeutics Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Cytomegalovirus Therapeutics Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cytomegalovirus Therapeutics Revenue and Market Share by Type (2012-2017)
4.3 United States Cytomegalovirus Therapeutics Price by Type (2012-2017)
4.4 United States Cytomegalovirus Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Cytomegalovirus Therapeutics Sales (Volume) by Application (2012-2017)
5.1 United States Cytomegalovirus Therapeutics Sales and Market Share by Application (2012-2017)
5.2 United States Cytomegalovirus Therapeutics Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Cytomegalovirus Therapeutics Players/Suppliers Profiles and Sales Data
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Actavis
6.2.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Actavis Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Clinigen Group
6.3.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Clinigen Group Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Merck
6.4.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Merck Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Perrigo Company
6.5.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Perrigo Company Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Roche
6.6.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Roche Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Valeant Pharmaceuticals
6.7.2 Cytomegalovirus Therapeutics Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
...

7 Cytomegalovirus Therapeutics Manufacturing Cost Analysis
7.1 Cytomegalovirus Therapeutics Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cytomegalovirus Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Cytomegalovirus Therapeutics Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cytomegalovirus Therapeutics Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Cytomegalovirus Therapeutics Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Cytomegalovirus Therapeutics Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cytomegalovirus Therapeutics Sales Volume Forecast by Type (2017-2022)
11.3 United States Cytomegalovirus Therapeutics Sales Volume Forecast by Application (2017-2022)
11.4 United States Cytomegalovirus Therapeutics Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Cytomegalovirus Therapeutics
Figure United States Cytomegalovirus Therapeutics Market Size (K Pcs) by Type (2012-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume Market Share by Type (Product Category) in 2016
Figure Ganciclovir/Valganciclovir Product Picture
Figure Foscarnet Product Picture
Figure Cidofovir Product Picture
Figure United States Cytomegalovirus Therapeutics Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Cytomegalovirus Therapeutics by Application in 2016
Figure CMV Retinitis Examples
Figure Pneumonia Examples
Figure Gastrointestinal Ulcers Examples
Figure Encephalitis Examples
Figure Mouth Ulcers Examples
Figure Pharyngitis Examples
Figure United States Cytomegalovirus Therapeutics Market Size (Million USD) by Region (2012-2022)
Figure The West Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cytomegalovirus Therapeutics Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cytomegalovirus Therapeutics Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cytomegalovirus Therapeutics Sales Share by Players/Suppliers
Figure 2017 United States Cytomegalovirus Therapeutics Sales Share by Players/Suppliers
Figure United States Cytomegalovirus Therapeutics Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cytomegalovirus Therapeutics Revenue Share by Players/Suppliers
Figure 2017 United States Cytomegalovirus Therapeutics Revenue Share by Players/Suppliers
Table United States Market Cytomegalovirus Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Cytomegalovirus Therapeutics Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Cytomegalovirus Therapeutics Market Share of Top 3 Players/Suppliers
Figure United States Cytomegalovirus Therapeutics Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cytomegalovirus Therapeutics Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cytomegalovirus Therapeutics Product Category
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) by Region (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Region in 2016
Table United States Cytomegalovirus Therapeutics Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Revenue Market Share by Region (2012-2017)
Figure United States Cytomegalovirus Therapeutics Revenue Market Share by Region in 2016
Table United States Cytomegalovirus Therapeutics Price (USD/Pcs) by Region (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) by Type (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Share by Type (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Share by Type (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Type in 2016
Table United States Cytomegalovirus Therapeutics Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cytomegalovirus Therapeutics Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cytomegalovirus Therapeutics by Type (2012-2017)
Figure Revenue Market Share of Cytomegalovirus Therapeutics by Type in 2016
Table United States Cytomegalovirus Therapeutics Price (USD/Pcs) by Types (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Growth Rate by Type (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales (K Pcs) by Application (2012-2017)
Table United States Cytomegalovirus Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Application (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Market Share by Application in 2016
Table United States Cytomegalovirus Therapeutics Sales Growth Rate by Application (2012-2017)
Figure United States Cytomegalovirus Therapeutics Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure AbbVie Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure AbbVie Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Actavis Basic Information List
Table Actavis Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Actavis Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Actavis Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Actavis Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Clinigen Group Basic Information List
Table Clinigen Group Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Clinigen Group Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Clinigen Group Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Clinigen Group Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Merck Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Merck Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Perrigo Company Basic Information List
Table Perrigo Company Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Perrigo Company Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Perrigo Company Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Perrigo Company Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Roche Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Roche Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Valeant Pharmaceuticals Basic Information List
Table Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales Growth Rate (2012-2017)
Figure Valeant Pharmaceuticals Cytomegalovirus Therapeutics Sales Market Share in United States (2012-2017)
Figure Valeant Pharmaceuticals Cytomegalovirus Therapeutics Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cytomegalovirus Therapeutics
Figure Manufacturing Process Analysis of Cytomegalovirus Therapeutics
Figure Cytomegalovirus Therapeutics Industrial Chain Analysis
Table Raw Materials Sources of Cytomegalovirus Therapeutics Major Players/Suppliers in 2016
Table Major Buyers of Cytomegalovirus Therapeutics
Table Distributors/Traders List
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Cytomegalovirus Therapeutics Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cytomegalovirus Therapeutics Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Cytomegalovirus Therapeutics Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Cytomegalovirus Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cytomegalovirus Therapeutics Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *